BioLargo's market cap is currently $76.41M. The company's EPS TTM is $-0.007; its P/E ratio is ―; BioLargo is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 12.23M	$ 5.88M	$ 2.53M	$ 2.43M	$ 1.86M
Gross Profit	$ 6.15M	$ 2.86M	$ 1.10M	$ 1.23M	$ 916.00K
Operating Income	$ -4.19M	$ -5.12M	$ -6.38M	$ -7.45M	$ -6.48M
EBITDA	$ -4.19M	$ -5.10M	$ -6.70M	$ -7.83M	$ -7.44M
Net Income	$ -3.50M	$ -4.50M	$ -7.38M	$ -10.47M	$ -14.75M
Balance Sheet
Cash & Short-Term Investments	$ 3.54M	$ 1.85M	$ 962.00K	$ 716.00K	$ 655.00K
Total Assets	$ 8.21M	$ 4.86M	$ 3.02M	$ 4.94M	$ 3.62M
Total Debt	$ 1.70M	$ 1.47M	$ 1.13M	$ 2.67M	$ 4.52M
Net Debt	$ -1.84M	$ -383.00K	$ 171.00K	$ 1.96M	$ 3.87M
Total Liabilities	$ 4.00M	$ 2.85M	$ 2.09M	$ 5.18M	$ 5.80M
Stockholders' Equity	$ 6.84M	$ 4.88M	$ 4.65M	$ 3.86M	$ -2.15M
Cash Flow
Free Cash Flow	$ -2.84M	$ -3.03M	$ -3.97M	$ -4.18M	$ -4.46M
Operating Cash Flow	$ -2.37M	$ -2.76M	$ -3.94M	$ -4.15M	$ -4.42M
Investing Cash Flow	$ -478.00K	$ -271.00K	$ -34.00K	$ -123.00K	$ -35.00K
Financing Cash Flow	$ 4.66M	$ 3.96M	$ 4.23M	$ 4.34M	$ 4.47M

Currency in USD

BioLargo Earnings and Revenue History

Income Statement >

BioLargo Debt to Assets

Balance Sheet >

BioLargo Cash Flow

Cash Flow >

BioLargo Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing